AAAAAA
Results:
1-20
|
Results: 20
Authors:
Gandjour, A
Westenhofer, J
Wirth, A
Fuchs, C
Lauterbach, KW
Citation: A. Gandjour et al., Development process of an evidence-based guideline for the treatment of obesity, INT J QUAL, 13(4), 2001, pp. 325-332
Authors:
Gandjour, A
Lauterbach, KW
Citation: A. Gandjour et Kw. Lauterbach, The relationship between provider volume and mortality rate: volume data of German centres of excellence, Z KARDIOL, 90(9), 2001, pp. 613
Authors:
Gandjour, A
Lauterbach, KW
Citation: A. Gandjour et Kw. Lauterbach, A method for assessing the cost-effectiveness and the break-even point of clinical practice guidelines, INT J TE A, 17(4), 2001, pp. 503-516
Authors:
Lungen, M
Lauterbach, KW
Citation: M. Lungen et Kw. Lauterbach, Upcoding - does it jeopardize the use of DRG?, DEUT MED WO, 125(28-29), 2000, pp. 852-856
Authors:
Lauterbach, KW
Binnen, T
Evers, T
Harnischmacher, U
Ludwig, D
Hanrath, P
Krone, W
Lehmacher, W
Leys, D
Neuhaus, KL
Windler, E
Citation: Kw. Lauterbach et al., Primary prevention of stroke: RESPECT, EUR H J SUP, 2(D), 2000, pp. D51-D53
Authors:
Lauterbach, KW
Citation: Kw. Lauterbach, Socioeconomic aspects in the treatment of cardiologic diseases, HERZ, 25(5), 2000, pp. 473-475
Authors:
Hinzpeter, B
Klever-Deichert, G
Wendland, G
Lauterbach, KW
Citation: B. Hinzpeter et al., Coronary heart disease and social security - a simulation model on cost analysis, HERZ, 25(5), 2000, pp. 515-525
Authors:
Dietlein, M
Weber, K
Gandjour, A
Moka, D
Theissen, P
Lauterbach, KW
Schicha, H
Citation: M. Dietlein et al., Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results, EUR J NUCL, 27(11), 2000, pp. 1598-1609
Authors:
Dietlein, M
Weber, K
Gandjour, A
Moka, D
Theissen, P
Lauterbach, KW
Schicha, H
Citation: M. Dietlein et al., Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany, EUR J NUCL, 27(10), 2000, pp. 1441-1456
Authors:
Weber, C
Lauterbach, KW
Citation: C. Weber et Kw. Lauterbach, Pharmacoeconomics - Levels of economic evaluations for drugs, INTERNIST, 41(4), 2000, pp. 349-354
Authors:
Lungen, M
Lauterbach, KW
Citation: M. Lungen et Kw. Lauterbach, International comparison of use of diagnosis-related groups (DRG), CHIRURG, 71(10), 2000, pp. 1288-1295
Authors:
Hinzpeter, B
Klever-Deichert, G
Lauterbach, KW
Citation: B. Hinzpeter et al., Cost effectiveness of treating high-risk individuals aged 45-65 years withstatins in Germany for primary and secondary prevention of coronary heart disease from the perspective of the social security system, EUR H J SUP, 1(M), 1999, pp. M33-M38
Authors:
Dietlein, M
Moka, D
Dederichs, B
Hunsche, E
Lauterbach, KW
Schicha, H
Citation: M. Dietlein et al., Cost-effectiveness-analysis: Radioiodine or antithyroid drugs as first-line therapy of hyperthyroidism due to Graves' disease, NUKLEARMED, 38(1), 1999, pp. 7-14
Authors:
Bergemann, R
Lauterbach, KW
Vanscheidt, W
Neander, KD
Engst, R
Citation: R. Bergemann et al., Economic evaluation of the treatment of chronic wounds - Hydroactive wounddressings in combination with enzymatic ointment versus gauze dressings inpatients with pressure ulcer and venous leg ulcer in Germany, PHARMACOECO, 16(4), 1999, pp. 367-377
Authors:
Gandjour, A
Lauterbach, KW
Citation: A. Gandjour et Kw. Lauterbach, Review of quality-of-life evaluations in patients with angina pectoris, PHARMACOECO, 16(2), 1999, pp. 141-152
Authors:
Steiner, S
Lauterbach, KW
Citation: S. Steiner et Kw. Lauterbach, Development of evidence-based clinical practice guidelines: a model project integrating external evidence apd clinical expertise, MED KLIN, 94(11), 1999, pp. 643-647
Authors:
Dietlein, M
Knapp, WH
Lauterbach, KW
Schicha, H
Citation: M. Dietlein et al., Economic evaluation studies in nuclear medicine: the need for standardization, EUR J NUCL, 26(6), 1999, pp. 663-680
Authors:
Klever-Deichert, G
Hinzpeter, B
Hunsche, E
Lauterbach, KW
Citation: G. Klever-deichert et al., Life time cost of coronary heart disease in Germany - A study from the perspective of society, Z KARDIOL, 88(12), 1999, pp. 991-1000
Authors:
Gandjour, A
Lauterbach, KW
Citation: A. Gandjour et Kw. Lauterbach, Problems of rationing in the context of limited financial resources, INTERNIST, 40(3), 1999, pp. 255-259
Authors:
Dietlein, M
Lauterbach, KW
Schicha, H
Citation: M. Dietlein et al., Treatment of toxic nodular goitres: Comparative costing of radioiodine therapy and surgery, EXP CL E D, 106, 1998, pp. S66-S70
Risultati:
1-20
|